IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
JFL Life Sciences IPO offer price is ₹ 61.00 and got listed at ₹ 66.50. Read IPO details mentioned above.
JFL Life Sciences IPO listing price is ₹ 66.50, issue price is ₹ 61.00, and currently trading at ₹ 18.75 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
JFL Life Sciences IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. GYR Capital Advisors is the merchant banker of JFL Life Sciences IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th April 2022.
JFL Life Sciences IPO offer price is ₹ 61.00 and got listed at ₹ 66.50. Read Infraprime Logistics Technologies IPO details mentioned above.JFL Life Sciences IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Manufacturing of pharmaceutical products. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. JFL Life Sciences IPO size is ₹ 18.17 Cr. with fresh issue size of ₹ 18.17 Cr. and Offer for sale being Nil
The IPO allotment date for JFL Life Sciences IPO is expected to be 5th September 2022, after the finalization of basis of allotment. Investors can check JFL Life Sciences IPO allotment status on the registrars website, Kfin Technologies Limited. JFL Life Sciences IPO refund dates are 6th September 2022.
JFL Life Sciences IPO is expected to be listed on 8th September 2022.
The upper price band for the JFL Life Sciences IPO is set at ₹ 61.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on JFL Life Sciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the JFL Life Sciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 30th August 2022. After submission, funds are blocked until the basis of allotment of JFL Life Sciences IPO is finalised.
The merchant banker for JFL Life Sciences IPO is GYR Capital Advisors Private Limited . GYR Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the JFL Life Sciences IPO RHP for further details.
The registrar for JFL Life Sciences IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to JFL Life Sciences IPO through their official website or helpline.
JFL Life Sciences IPO was subscribed 8.93 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:JFL Life Sciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on JFL Life Sciences Financial Review Page
Merchant Banker(s) of JFL Life Sciences IPO: GYR Capital Advisors Private Limited
JFL Life Sciences IPO subscription was 8.93 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
JFL Life Sciences IPO listed at a listing price of 66.50 against the offer price of 61.00.
The current market price of JFL Life Sciences is 18.75.
Why Us?
